Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) GROUP BASED ON MEDICARE | Back to Top |
| DRG Code | DRG Description | Category | Sub Category | DRG Group | Surgical Category | Case Mix Level | Total National Projected Hospitalizations - Annualized | Total Medicare Hospitalizations - Jan 2017 to Dec 2017 | Total Medicare Hospitalizations - Jan 2013 to Dec 2017 | Total Medicare Hospitalizations After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 814 | RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | Non Surgical | 28.42 | NA | 1,754 | 8,260 | 7,376 | ||||||||||||
| 815 | RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | Non Surgical | 53.34 | NA | 2,955 | 15,504 | 14,704 | ||||||||||||
| 816 | RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | Non Surgical | 18.25 | NA | 1,019 | 5,304 | 5,042 |
DEMOGRAPHIC DETAILS OF DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Race | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| White | 6,339 | 76.74 |
| Black | 1,295 | 15.68 |
| Hispanic | 238 | 2.88 |
| Age Group ( Years ) | Total Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|
| Less than 65 | 2,329 | 28.2 |
| Greater than 84 | 1,384 | 16.76 |
| 65 to 69 | 1,251 | 15.15 |
TOP ICD DIAGNOSIS CODES FOR DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 28860 | Leukocytosis, unspecified | 1,698 | 20.56 |
| 4019 | Unspecified essential hypertension | 1,471 | 17.81 |
| 2724 | Other and unspecified hyperlipidemia | 1,392 | 16.85 |
TOP ICD PROCEDURE CODES FOR DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| ICD Code | ICD Description | Total Procedure ICD & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|
| 3995 | Hemodialysis | 879 | 10.64 |
| 9904 | Transfusion Of Packed Cells | 719 | 8.7 |
| 30233N1 | Transfusion of Nonautologous Red Blood Cells into Peripheral Vein, Percutaneous Approach | 418 | 5.06 |
TOP HOSPITALS ASSOCIATED WITH DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | Back to Top |
| Hospital Name | Address | City | State | Zip Code | Total Hospital & DRG Hospitalization Volume - Jan 2013 to Dec 2017 | % of DRG Volume |
|---|---|---|---|---|---|---|
| AdventHealth Orlando | 601 E ROLLINS ST | Orlando | FL | 32803 | 43 | 0.52 |
| Methodist University Hospital | 1265 UNION AVE | Memphis | TN | 38104 | 29 | 0.35 |
| University of California Davis Medical Center | 2315 STOCKTON BLVD | Sacramento | CA | 95817 | 28 | 0.34 |
DRG 814: RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) SUMMARY TABLE | Back to Top |
| Category | Sub Category | DRG Group | ICD Codes | ICD Description | National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 | National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 | National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 | Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 | Total Discharges After Exclusion | Avg. LOS | GMLOS | All Cause Readmission Rate (%) | Unplanned Readmission Rate (%) | Total Medicare Payments | Payment per Day | Payment per Discharge | Total Medicare Charges | Avg. Charges | Mortality Rate (%) | SNF Discharge Rate (%) | Home Discharge Rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 28860 | Leukocytosis, unspecified | NA | 1,698 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 4019 | Unspecified essential hypertension | NA | 1,471 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | I10 | Essential (primary) hypertension | 1,279 | 1,395 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 2724 | Other and unspecified hyperlipidemia | NA | 1,392 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | E785 | Hyperlipidemia, unspecified | 994 | 1,364 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | I2510 | Atherosclerotic heart disease of native coronary artery without angina pectoris | 756 | 1,044 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 5856 | End stage renal disease | NA | 1,041 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 4280 | Congestive heart failure, unspecified | NA | 1,020 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | 25000 | Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled | NA | 990 | |||||||||||||||||
| Oncology & Hematology | Reticuloendothelial And Immunity Disorders | Reticuloendothelial And Immunity Disorders | D72829 | Elevated white blood cell count, unspecified | 671 | 969 |